Sign in →

Test Code EBVP EBV Antibody Panel

Important Note

Testing at Munson Medical Center Laboratories coming soon!  Order Mayo sendout test EBVAB EBVAB - Overview: Epstein-Barr Virus Antibody Profile, Serum

EHR Test Codes

  Test Code Test Name
Atlas EBVP Epstein-Barr Virus Antibody Panel
Cerner   EBV Antibody Panel

Specimen Requirements

Preparation of Patient: 

None

 

Container Type: 

Gold Top 6mL SST Gel & Clot Activator Tube

Specimen Type:

Serum

 

Specimen Volume: 

2.5 mL Serum minimum 0.3 mL

 

Specimen Handling/Transport:

Transport refrigerated 2 - 8°C

 

Specimen Stability/Storage:

 2 days refrigerated 2 - 8°C

7 days frozen -20°C

 

Specimen Rejection:

Gross hemolysis

Gross lipemia

Gross icterus

Performing Laboratory

Munson Medical Center Laboratories

Chemistry Department

Priority, Frequency, & Turnaround

Priority:

Non-Emergent

 

Frequency:

Wednesday

 

Turnaround:

0 - 7 days

Methodology

Chemiluminescence Immunoassay

 

Panel Includes: EBV Viral Capsid Antigen IgM (VCA IgM), EBV Viral Capsid Antigen IgG  (VCA IgG), EBV Early Antigen IgG (EA), and Epstein-Barr Nuclear Antigen IgG (EBNA)

Reporting

Reference Range:

Negative

 

Interpretive Data:

Equivocal result indicates that a second sample should be retested in no less than 1 to 2 weeks, if clinically indicated.

 

Flow Diagram:

The accurate distinction of a primary (acute) infection from seronegative status or past infection is a key concern of EBV diagnostics. The presence of other EBV serological markers should be determined to assess the immunological status to infection with EBV.  Based on the results of antibody tests, distinct serological profiles have been described in the medical literature.

 

Condition VCA IgM VCA IgG EBNA   EBV EA
No Past Infection - - - -
Past Infection - + + -
Acute Infection + + - +
Recent Infection ± + + ±
Convalescent + + + +

 

Because some individuals are reported to exhibit long-lasting EBV VCA IgM antibodies, the convalescent pattern may represent a transient period late in the primary infection stage or may persist well into the past infection stage. Thus, it is considered an indeterminate pattern. For samples that exhibit indeterminate patterns, further diagnostic testing may be required. In all cases, diagnosis of infectious diseases should not be established on the basis of a single test result, but should be determined in conjunction with clinical findings and other diagnostic procedures as well as in association with medical judgment

 

Critical Decision: 

None

Clinical Significance

Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and is implicated in Burkitt's lymphoma and nasopharyngeal carcinoma.  Antibody response profiles for the different EBV antigens demonstrate a characteristic pattern for silent primary or persistent latent EBV infections, as well as for each of the EBV-associated diseases.

CPT Code(s)

86663

86664

86665

86666